|
US8912196B2
(en)
|
2009-05-27 |
2014-12-16 |
Atir Holding S.A. |
Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
|
|
KR101178181B1
(ko)
*
|
2010-09-17 |
2012-09-19 |
대한민국(농촌진흥청장) |
신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물
|
|
WO2012049555A1
(en)
|
2010-10-13 |
2012-04-19 |
Lupin Limited |
Spirocyclic compounds as voltage-gated sodium channel modulators
|
|
AU2012279091A1
(en)
*
|
2011-07-06 |
2014-01-16 |
Glaxo Group Limited |
Voltage-gated sodium channel blockers
|
|
WO2013064983A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
EP2773641B1
(en)
|
2011-10-31 |
2017-09-27 |
Xenon Pharmaceuticals Inc. |
Biaryl ether sulfonamides and their use as therapeutic agents
|
|
CA3142817A1
(en)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
|
SG11201408284VA
(en)
|
2012-05-22 |
2015-02-27 |
Xenon Pharmaceuticals Inc |
N-substituted benzamides and their use in the treatment of pain
|
|
US10071957B2
(en)
|
2012-07-06 |
2018-09-11 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
ES2750640T3
(es)
*
|
2012-08-16 |
2020-03-26 |
Scripps Research Inst |
Ligandos opioides kappa novedosos
|
|
RU2015143906A
(ru)
|
2013-03-14 |
2017-04-18 |
Дженентек, Инк. |
Замещенные триазолопиридины и способы их применения
|
|
BR112015022385A2
(pt)
*
|
2013-03-14 |
2017-07-18 |
Daiichi Sankyo Co Ltd |
droga para uma doença respiratória
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP3919056B1
(en)
|
2013-03-15 |
2024-08-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP2968299B1
(en)
|
2013-03-15 |
2021-01-20 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
US9493429B2
(en)
|
2013-03-15 |
2016-11-15 |
Genentech, Inc. |
Substituted benzoxazoles and methods of use thereof
|
|
EA201591427A1
(ru)
*
|
2013-03-15 |
2016-01-29 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
CN112500338A
(zh)
|
2013-03-15 |
2021-03-16 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
|
WO2014165816A1
(en)
|
2013-04-05 |
2014-10-09 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
EA202092627A1
(ru)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
AU2014356967A1
(en)
|
2013-11-27 |
2016-07-07 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
US9975876B2
(en)
|
2013-12-09 |
2018-05-22 |
Merck Sharp & Dohme Corp. |
2-pyridyloxy-3-ester-4-ether orexin receptor antagonists
|
|
JP6045487B2
(ja)
*
|
2013-12-25 |
2016-12-14 |
シャープ株式会社 |
操作入力システム、電子機器、携帯端末、及び操作入力方法
|
|
SG10201911662YA
(en)
|
2014-02-07 |
2020-02-27 |
Global Blood Therapeutics Inc |
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
CN106255679B
(zh)
*
|
2014-02-27 |
2019-09-06 |
默克专利有限公司 |
用作nav通道抑制剂的杂环化合物及其用途
|
|
AU2015242219A1
(en)
|
2014-03-29 |
2016-10-06 |
Lupin Limited |
Sulfonamide compounds as Voltage gated sodium channel modulators
|
|
JP2017525677A
(ja)
|
2014-07-07 |
2017-09-07 |
ジェネンテック， インコーポレイテッド |
治療用化合物及びその使用方法
|
|
WO2016021742A1
(en)
|
2014-08-07 |
2016-02-11 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds as ep4 receptor antagonists
|
|
BR112017024853A2
(pt)
|
2015-05-22 |
2018-08-07 |
Genentech Inc |
composto, composição farmacêutica, método para tratar uma doença ou condição em um mamífero, para tratamento de prurido em um mamífero, para tratamento ou profilaxia e uso de um composto
|
|
MA42683A
(fr)
|
2015-08-27 |
2018-07-04 |
Genentech Inc |
Composés thérapeutiques et leurs méthodes utilisation
|
|
TW201722938A
(zh)
|
2015-09-04 |
2017-07-01 |
魯賓有限公司 |
作為電位閘控鈉通道調節子之磺醯胺化合物
|
|
SG10202007787RA
(en)
|
2015-09-28 |
2020-09-29 |
Genentech Inc |
Therapeutic compounds and methods of use thereof
|
|
JP2018535234A
(ja)
|
2015-11-25 |
2018-11-29 |
ジェネンテック， インコーポレイテッド |
ナトリウムチャネル遮断薬として有用な置換ベンズアミド
|
|
HUE072191T2
(hu)
|
2015-12-04 |
2025-10-28 |
Global Blood Therapeutics Inc |
A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje
|
|
JP2019505508A
(ja)
|
2016-02-03 |
2019-02-28 |
シャンハイ ハイヤン ファーマシューティカル テクノロジー カンパニー リミテッドＳｈａｎｇｈａｉ Ｈａｉｙａｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．， Ｌｔｄ． |
複素環置換ｎ−スルホニルベンズアミド誘導体、その製造方法および医薬における使用
|
|
WO2017172802A1
(en)
|
2016-03-30 |
2017-10-05 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
TWI825524B
(zh)
|
2016-05-12 |
2023-12-11 |
美商全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
|
SG11201903348UA
(en)
|
2016-10-17 |
2019-05-30 |
Genentech Inc |
Therapeutic compounds and methods of use thereof
|
|
WO2018163077A1
(en)
|
2017-03-08 |
2018-09-13 |
Lupin Limited |
Indanyl compounds as voltage gated sodium channel modulators
|
|
CN110546148A
(zh)
|
2017-03-24 |
2019-12-06 |
基因泰克公司 |
作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物
|
|
EP3759098A1
(en)
|
2018-02-26 |
2021-01-06 |
Genentech, Inc. |
Pyridine-sulfonamide compounds and their use against pain and related conditions
|
|
CN111936494A
(zh)
|
2018-03-30 |
2020-11-13 |
豪夫迈·罗氏有限公司 |
作为钠通道抑制剂的取代的氢-吡啶并-吖嗪
|
|
TW202003490A
(zh)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|
|
US11014884B2
(en)
|
2018-10-01 |
2021-05-25 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin
|
|
CN109796402A
(zh)
*
|
2018-12-28 |
2019-05-24 |
京博农化科技有限公司 |
一种烟嘧磺隆中间体2-氯-n，n-二甲基烟酰胺的制备方法
|
|
KR102845511B1
(ko)
*
|
2019-02-08 |
2025-08-12 |
삼성디스플레이 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
CN113543852A
(zh)
|
2019-03-06 |
2021-10-22 |
第一三共株式会社 |
吡咯并吡唑衍生物
|